TFI International Increases Dividend Despite Drop in Profit
TFI International announces a 14% increase in dividend despite lower profit and revenue in Q3. CEO expresses optimism for future growth.
- Thursday, October 17, 2024
News
Technology Stocks Rise as Earnings Forecasts Climb
Technology stocks are gaining optimism as earnings forecasts improve, despite recent declines. Analysts have revised profit forecasts upwards, and tec...
Andrew R. Michaud
Tesla Faces Legal Challenges and Investigations
Tesla Inc. is dealing with legal challenges and investigations regarding their Autopilot and Full Self Driving systems, as well as allegations of anti...
Andrew R. Michaud
Novartis Set to Report Q3 Results
Novartis is set to announce their Q3 results, with analysts estimating lower sales but higher core net profit. Key drugs and guidance will be closely...
Andrew R. Michaud
Volkswagen Adjusts Full-Year Guidance After Third-Quarter Performance Setback
Shares in Volkswagen decline as the company adjusts its full-year profit forecast due to production losses and increased costs. Analysts express surpr...
Andrew R. Michaud
Mission Group Cancels Dividend and Lowers Profit Forecast
Mission Group, a U.K. marketing company, cancels dividend and lowers profit forecast due to challenging trading conditions. Anticipated adjusted preta...
Andrew R. Michaud
Pfizer Receives FDA Approval for Penbraya Vaccine
Pfizer has received FDA approval for Penbraya, a highly effective vaccine to prevent meningococcal disease in adolescents and young adults. The CDC em...
Andrew R. Michaud
U.S. Stock Markets Experience Losses
The U.S. stock market is facing a downward trend due to rising Treasury yields, leading to weekly losses for major indices. Investors are concerned ab...
Andrew R. Michaud
Nvidia Faces Pressure from Stricter Export Restrictions to China
Analysts predict stock pressure for Nvidia as stricter export restrictions to China affect the company's revenues. Concerns arise about the long-term...
Andrew R. Michaud
Keytruda Plus Chemotherapy Shows Positive Results for Rare Form of Esophageal Cancer
A late-stage trial of Keytruda Plus Chemotherapy has shown positive results in treating a rare form of esophageal cancer, reducing the risk of death a...
Andrew R. Michaud
All Rights Reserved © 2024